Benitec Biopharma Inc.BNTCNASDAQ
LOADING
|||
EPS Growth Under Pressure
Trending lower, above historical average.
Left:
||||
Year-over-year earnings per share growth rate
Latest
60.82%
↑ 6631% above average
Average (9y)
-0.93%
Historical baseline
Range
High:127.46%
Low:-342.89%
CAGR
NaN%
Modest growth trend
| Period | Value |
|---|---|
| 2025 | 60.82% |
| 2024 | 81.02% |
| 2023 | 26.88% |
| 2022 | 29.19% |
| 2021 | 60.53% |
| 2020 | -342.89% |
| 2019 | 127.46% |
| 2018 | -63.02% |
| 2017 | 80.83% |
| 2016 | -70.13% |